Back to search

Article

Repurposing Diphenhydramine in Non-Small Cell Lung Cancer: A Mitochondrial Redox Mechanism and a Derived Prognostic Gene Signature

2026-03-11

Abstract excerpt

<title>Abstract</title> <p>Diphenhydramine (DIPH) is a widely used first-generation H1 antihistamine. While multiple antihistamines have recently shown noteworthy anticancer potential, the therapeutic efficacy of DIPH in non-small cell lung cancer (NSCLC) and its underlying mechanisms of action remain unreported. Here, we demonstrate that DIPH potently suppresses the viability, clonogenicity, migration, and invas...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
4a5030ce-9cb5-57d7-bef5-b61054ccaefe
DOI
10.21203/rs.3.rs-8900171/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Repurposing Diphenhydramine in Non-Small Cell Lung Cancer: A Mitochondrial Redox Mechanism and a Derived Prognostic Gene SignatureDOI 10.21203/rs.3.rs-8900171/v1
Select a neighboring publication to make it the new centre.